Yahoo Finance • 9 hours ago
Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening WALTHAM, Mass., October 02, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a program... Full story
Yahoo Finance • 2 days ago
[U.S. President Donald Trump Visits Scotland For Rounds Of Golf And Trade Talks] Christopher Furlong Announcing an agreement with Pfizer (NYSE:PFE [https://seekingalpha.com/symbol/PFE]) to offer all brand-name drugs marketed by the compan... Full story
Yahoo Finance • 2 days ago
[Influenza vaccine in a vial, immunization and treatment of infection] Kittisak Kaewchalun * Novavax (NASDAQ:NVAX [https://seekingalpha.com/symbol/NVAX]) has expanded a license agreement that will allow Sanofi (NASDAQ:SNY [https://seeki... Full story
Yahoo Finance • 3 days ago
GSK stock jumped back into a buy zone Monday after announcing Chief Executive Emma Walmsley will step down at the end of the year. Continue Reading View Comments... Full story
Yahoo Finance • 6 days ago
This article first appeared on GuruFocus. Global pharma stocks slipped Friday after President Donald Trump unveiled one of his toughest trade moves yet: a 100% tariff on branded and patented drugs starting October 1. Companies that are al... Full story
Yahoo Finance • 6 days ago
[Sealed Bottle of Extra Strength Tylenol Caplets with Box] skhoward/iStock Unreleased via Getty Images * President Trump on Friday warned pregnant women not to take Tylenol (acetaminophen) "unless absolutely necessary," repeating commen... Full story
Yahoo Finance • 7 days ago
[Many different pills on pink background. Prescription pills and vitamins. Flat lay and space for text.] Baurzhan Ibrashev European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, in... Full story
Yahoo Finance • 7 days ago
[Sanofi Distribution Centre in Kirkland, Quebec, Canada.] JHVEPhoto/iStock Editorial via Getty Images * The FDA has withdrawn the Risk Evaluation and Mitigation Strategies (REMS) program for Sanofi's (NASDAQ:SNY [https://seekingalpha.co... Full story
Yahoo Finance • 7 days ago
[President Trump Makes Announcement On New Theories On Autism Causation In Children] Andrew Harnik/Getty Images News Health and Human Services Secretary Robert F. Kennedy Jr. is considering plans to add certain autism symptoms to a list o... Full story
Yahoo Finance • 8 days ago
[Sanofi Distribution Centre in Kirkland, Quebec, Canada.] JHVEPhoto/iStock Editorial via Getty Images An appeals court in France on Wednesday ordered Sanofi (NASDAQ:SNY [https://seekingalpha.com/symbol/SNY]) and its Winthrop Industrie sub... Full story
Yahoo Finance • 9 days ago
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund will remain focused on Sanofi's key areas of immunology, rare diseases, neurology, and vaccines, backi... Full story
Yahoo Finance • 9 days ago
Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique Le fonds restera axé sur les domaines clés de Sanofi q... Full story
Yahoo Finance • 9 days ago
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025. Sanofi announced today that its Q3 2025 Aide mémoire is available on the "Investors" page of the company's website: Third quarter 2025 (sanofi.com) As for each... Full story
Yahoo Finance • 9 days ago
Mise en ligne du document «Q3 2025 Aide mémoire » Paris, France, le 24 septembre 2025. Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q3 2025 Aide mémoire ». Résultats... Full story
Yahoo Finance • 10 days ago
Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Designation earned for one-time AAV gene therapy SAR446268, designed to silence DMPK expressionMyotonic dystrophy type 1 (DM1... Full story
Yahoo Finance • 10 days ago
La thérapie SAR446268 de Sanofi obtient son admission dans la procédure accélérée américaine pour le traitement de la dystrophie myotonique non congénitale de type 1 Admission obtenue pour la thérapie génique AAV unique SAR446268, conçue... Full story
Yahoo Finance • 10 days ago
If you’re following Sanofi (ENXTPA:SAN), you may have noticed the stock’s recent moves have caught the eye of investors wondering what comes next. Without a clear news trigger or dramatic headline event, it is the kind of situation that dr... Full story
Yahoo Finance • 11 days ago
[Research Shows Acetaminophen Relieves Not Just Pain, But Emotions As Well] Scott Olson/Getty Images News The Trump administration on Monday plans to link the use of the popular painkiller Tylenol to a risk of autism, the _Washington Post... Full story
Yahoo Finance • 11 days ago
Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis Paris, September 22, 2025. The US Food and Drug Administration (FDA) has extended by three months the target action date of its... Full story
Yahoo Finance • 11 days ago
Mise à jour sur l’examen réglementaire américain du tolébrutinib dans le traitement de la sclérose en plaques secondairement progressive non récurrente Paris, le 22 septembre 2025. La Food and Drug Administration (FDA) des États-Unis a pr... Full story